The Role of Early Magnetic Resonance Imaging in Predicting Survival on Bevacizumab for Recurrent Glioblastoma: Results From a Prospective Clinical Trial (CABARET)

Cancer - United States
doi 10.1002/cncr.30838
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Role of Magnetic Resonance Imaging and Clinical Assessments in Predicting Meniscal Tear Surgery

Eklem Hastaliklari ve Cerrahisi
SurgeryOrthopedicsSports MedicineRehabilitation
2019English

Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2014English

Role of Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Differentiating Post Therapeutic Changes From Recurrent Malignant Breast Lesions

The Medical Journal of Cairo University
2019English

Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience

Neurology
Neurology
2009English

Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2020English

The Role of Gadolinium in Magnetic Resonance Imaging for Early Prostate Cancer Diagnosis: A Diagnostic Accuracy Study

PLoS ONE
Multidisciplinary
2019English

Sustained Focal Antitumor Activity of Bevacizumab in Recurrent Glioblastoma

Neurology
Neurology
2014English

Magnetic Resonance Imaging for Diagnosis of Early Alzheimer's Disease

Revue Neurologique
Neurology
2013English

Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)

Hepatology
MedicineHepatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy